Víctor D Rosenthal1, Souad Belkebir2, Farid Zand3, Majeda Afeef4, Vito L Tanzi5, Hail M Al-Abdely6, Amani El-Kholy7, Safa A Aziz AlKhawaja8, Ali P Demiroz9, Amani F Sayed10, Naheed Elahi11, May O Gamar-Elanbya12, Khalid Abidi13, Najla Ben-Jaballah14, Mona F Salama15, Najla J Helali16, Mona M Abdel-Halim17, Nadia L Demaisip18, Hala Ahmed19, Hanan H Diab20, Apsia M Molano21, Fahad A Sawan22, Ashraf Kelany23, Rami Altowerqi24, Hala Rushdi25, Modhi A Alkamaly26, Eatedal Bohlega27, Hajer A Aldossary28, Kareem M Abdelhady29, Aamer Ikram30, Marjory Madco31, Yvonne Caminade32, Muneefah Alazmi33, Tahsine Mahfouz34, Reham H Abdelaziz-Yousef35, Ahmed Ibrahim36, Basma Elawady37, Tasmiya Asad38, Leide Shyrine39, Hakan Leblebicioglu40. 1. International Nosocomial Infection Control Consortium, Buenos Aires, Argentina. Electronic address: victor_rosenthal@inicc.org. 2. Assistant professor, An Najah National University, An Najah University Hospital, Nablus, Palestine. 3. Anesthesiology and Critical Care Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. 4. King Hussein Cancer Center, Amman, Jordan. 5. Hammoud Hospital University Medical Center, Saida, Lebanon. 6. General Directorate of Infection Prevention and Control, Ministry of Health, Saudi Arabia. 7. Dar Al Fouad Hospital, 6th of October City, and Cairo University Hospital, Cairo, Egypt. 8. General Directorate of Infection Prevention and Control, Ministry of Health, Bahrain. 9. Ankara Training and Research Hospital, Ankara, Turkey. 10. Farwaniya Hospital, Kuwait City, Kuwait. 11. Dubai Hospital, Dubai, United Arab Emirates. 12. Royal Care International Hospital, Khartoum, Sudan. 13. Ibn Sina Hospital of Morocco, Rabat, Morocco. 14. Children Hospital Bechir Hamza of Tunis, Tunis, Tunisia. 15. Mubarak Al Kabir, Kuwait City, Kuwait. 16. King Abdulaziz Specialist Hospital, Taif, Saudi Arabia. 17. Children Hospital Cairo University Abu El Reesh, Cairo, Egypt. 18. Assir Central Hospital, Assir, Saudi Arabia. 19. Abha Maternity And Children Hospital, Assir, Saudi Arabia. 20. King Khalid Hospital, Najran, Saudi Arabia. 21. King Khalid Hospital, Tabuk, Saudi Arabia. 22. King Fahad Central Hospital, Jizan, Saudi Arabia. 23. King Abdulaziz Hospital and Oncology Center, Makkah, Saudi Arabia. 24. King Abdullah Medical Complex, Jeddah, Saudi Arabia. 25. Hera General Hospital, Makkah, Saudi Arabia. 26. King Khalid Hospital, Hail, Saudi Arabia. 27. King Salman Hospital, Riyadh, Saudi Arabia. 28. Dammam Maternity and Children Hospital, Damman, Saudi Arabia. 29. Cairo University Specialized Pediatric Hospital, Cairo, Egypt. 30. Armed Forces Institute of Pathology, Rawalpindi, Pakistan. 31. King Fahad Hospital, Jeddah, Saudi Arabia. 32. King Feisal Hospital, Taif, Saudi Arabia. 33. Prince Momhamed Bin Abdul Aziz Hospital, Riyadh, Saudi Arabia. 34. Sheikh Ragheb Harb Hospital, Nabatieh, Lebanon. 35. Internal Medicine Hospital, Cairo, Egypt. 36. King Fahad Hospital, Al Hasa, Saudi Arabia. 37. New Obgyn Kasr Alainy Hospital, Riyadh, Saudi Arabia. 38. King Saud Medical City of Riyadh, Riyadh, Saudi Arabia. 39. King Saud Hospital, Qassim, Saudi Arabia. 40. Ondokuz Mayis University Medical School, Samsun, Turkey.
Abstract
BACKGROUND: Short-term peripheral venous catheters-related bloodstream infections (PVCR-BSIs) rates have not been systematically studied, and data on their incidence by number of device-days is not available. METHODS: Prospective, surveillance study on PVCR-BSI conducted from September 1st, 2013 to 31st Mays, 2019 in 246 intensive care units (ICUs), members of the International Nosocomial Infection Control Consortium (INICC), from 83 hospitals in 52 cities of 14 countries in the Middle East (Bahrain, Egypt, Iran, Jordan, Kingdom of Saudi Arabia, Kuwait, Lebanon, Morocco, Pakistan, Palestine, Sudan, Tunisia, Turkey, and United Arab Emirates). We applied U.S. RESULTS: We followed 31,083 ICU patients for 189,834 bed-days and 202,375 short term peripheral venous catheter (PVC)-days. We identified 470 PVCR-BSIs, amounting to a rate of 2.32/1000 PVC-days. Mortality in patients with PVC but without PVCR-BSI was 10.38%, and 29.36% in patients with PVC and PVCR-BSI. The mean length of stay in patients with PVC but without PVCR-BSI was 5.94 days, and 16.84 days in patients with PVC and PVCR-BSI. The microorganism profile showed 55.2 % of gram-positive bacteria, with Coagulase-negative Staphylococci (31%) and Staphylococcus aureus (14%) being the predominant ones. Gram-negative bacteria accounted for 39% of cases, and included: Escherichia coli (7%), Klebsiella pneumoniae (8%), Pseudomonas aeruginosa (5%), Enterobacter spp. (3%), and others (29.9%), such as Serratia marcescens. CONCLUSIONS: PVCR-BSI rates found in our ICUs were much higher than rates published from USA, Australia, and Italy. Infection prevention programs must be implemented to reduce the incidence of PVCR-BSIs.
BACKGROUND: Short-term peripheral venous catheters-related bloodstream infections (PVCR-BSIs) rates have not been systematically studied, and data on their incidence by number of device-days is not available. METHODS: Prospective, surveillance study on PVCR-BSI conducted from September 1st, 2013 to 31st Mays, 2019 in 246 intensive care units (ICUs), members of the International Nosocomial Infection Control Consortium (INICC), from 83 hospitals in 52 cities of 14 countries in the Middle East (Bahrain, Egypt, Iran, Jordan, Kingdom of Saudi Arabia, Kuwait, Lebanon, Morocco, Pakistan, Palestine, Sudan, Tunisia, Turkey, and United Arab Emirates). We applied U.S. RESULTS: We followed 31,083 ICU patients for 189,834 bed-days and 202,375 short term peripheral venous catheter (PVC)-days. We identified 470 PVCR-BSIs, amounting to a rate of 2.32/1000 PVC-days. Mortality in patients with PVC but without PVCR-BSI was 10.38%, and 29.36% in patients with PVC and PVCR-BSI. The mean length of stay in patients with PVC but without PVCR-BSI was 5.94 days, and 16.84 days in patients with PVC and PVCR-BSI. The microorganism profile showed 55.2 % of gram-positive bacteria, with Coagulase-negative Staphylococci (31%) and Staphylococcus aureus (14%) being the predominant ones. Gram-negative bacteria accounted for 39% of cases, and included: Escherichia coli (7%), Klebsiella pneumoniae (8%), Pseudomonas aeruginosa (5%), Enterobacter spp. (3%), and others (29.9%), such as Serratia marcescens. CONCLUSIONS: PVCR-BSI rates found in our ICUs were much higher than rates published from USA, Australia, and Italy. Infection prevention programs must be implemented to reduce the incidence of PVCR-BSIs.
Authors: Mentor Ali Ber Lucien; Michael F Canarie; Paul E Kilgore; Gladzdin Jean-Denis; Natael Fénélon; Manise Pierre; Mauricio Cerpa; Gerard A Joseph; Gina Maki; Marcus J Zervos; Patrick Dely; Jacques Boncy; Hatim Sati; Ana Del Rio; Pilar Ramon-Pardo Journal: Int J Infect Dis Date: 2021-01-09 Impact factor: 3.623